Trypanosoma cruzi: The role of PGE2 in immune response during the acute phase of experimental infection

Experimental Parasitology

Volumn 118, Issue 4, 2008, Pages 514-521

  Abdalla, G K ^a   Faria, G E L ^a   Silva, K T ^a   Castro, E C C ^a   Reis, M A ^a   Michelin, M A ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

C; Ci; g ml; bovine serum albumin; BSA; Cardiac lesions; COX; COX 2; cyclooxygenase; Cytokines; degree Celsius; h; HE; hematoxylin eosin; hour; IFN ; Ig; IL; immunoglobulin; interferon ; interleukin; major histocompatibility complex; mg kg; MHC; micro Currier; micrograms per milliliter; milligrams per kilogram; nanograms per milliliter; ng ml; nitric oxide; NO; PBS; PGE2; phosphate buffered saline; Prostaglandin; prostaglandin E2; T helper; T. cruzi; Th; TNF ; Trypanosoma cruzi; tumor necrosis factor

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ETORICOXIB; MELOXICAM; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CHAGAS DISEASE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; MOUSE; MYOCARDITIS; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SPLEEN CELL; SURVIVAL RATE; TISSUE CULTURE; TRYPANOSOMA CRUZI;

ACUTE DISEASE; ANIMALS; CELLS, CULTURED; CHAGAS DISEASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FIBROSIS; MALE; MICE; MICE, INBRED BALB C; MYOCARDIUM; PARASITEMIA; PROSTAGLANDINS; PYRIDINES; SPLEEN; SULFONES; THIAZINES; THIAZOLES; TRYPANOSOMA CRUZI;

ANIMALIA; BOVINAE; MUS; TRYPANOSOMA CRUZI;

EID: 40649099340     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2007.11.003     Document Type: Article

References (45)

1. Abrahamsohn I., and Coffman R.L. Cytokine and nitric oxide regulation of the immunosupression in Trypanosoma cruzi infection. J. Immunol. 155 (1995) 39-55
2. Andrade S.G., et al. Immunological response of Swiss mice to infection with three different strains of Trypanosoma cruzi. Ann. Med. Trop. Parasitol. 79 (1985) 397-407
3. Andrade V., Andrade S.G., Netto M.B., Pontes A.L., and Castro R. Avaliação do comportamento de diferentes cepas do Trypanosoma cruzi na infecção de seis linhagens isogênicas de camundongos. Rev. Soc. Bras. Med. Trop. 18 (1985) 143-154
4. Antúnez M.I., and Cardoni R.L. Early IFN-g production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections. Immunol. Lett. 79 (2001) 189-196
5. Antúnez M.I., and Cardoni R.L. IL-12 and IFN-g production, and NK cell activity, in acute and chronic experimental Trypanosoma cruzi infections. Immunol. Lett. 71 (2000) 103-109
6. Borges M.M., Kloetzel J.K., Andrade Jr. H.F., Tadokoro C.E., Pinge Filho P., and Abrahamsohn I. Prostaglandin and nitric oxide regulate TNF-α production during Trypanosoma cruzi infection. Immunology 63 (1998) 1-8
7. Celentano A.M., Gorelik G., Solana M.E., Sterin Borda L., Borda E., and González Cappa S.M. PGE2 involvement in experimental infection with Trypanosoma cruzi subpopulations. Prostaglandins 49 (1995) 141-153
8. Chagas C. Nova tripanozomiaze humana. Mem. Inst. Oswaldo Cruz. 1 (1909) 3-71
9. Chandra M., Tanowitz H.B., Petkova S., Huang H., Weiss L.M., Wittner M., Factor S.M., Shtutin V., Jelicks L.A., Chan J., and Shirani J. Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). Int. J. Parasitol. 32 (2002) 897-905
10. 2 alpha in human urine. J. Endocrinol. Invest. 2 (1979) 173-182
11. Cunha Neto E., Duranti M., Gruber A., Zingales B., Messias I., Stolf N., Bellotti G., Patarroyo M.E., Pilleggi F., and Kalil J. Autoimmunity in Chagaś disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc. Natl. Acad. Sci. USA 92 (1995) 3541-3545
12. Da Silva A.P.G., and Abrahamsohn I.A. Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection. Immunology 104 (2001) 349-354
13. high activation phenotype and expression of IFN-γ inducible adhesion and chemoattractant molecules. Microbes Infect. 3 (2001) 971-984
14. Fernandez Gomez R., Esteban S., Gomez Corvera R., Zoulika K., and Ouaissi A. Trypanosoma cruzi: Tc 52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages. J. Immunol. 160 (1998) 3471
15. Freire De Lima C.G., Nascimento D.O., Soares M.B.P., Bozza P.T., Castro Faria Neto H.C., De Mello F.G., Dos Reis G.A., and Lopes M.F. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403 (2000) 199-203
16. Gazzinelli R.T., Oswald I.P., Hieny S., James S.L., and Sher A. The microbicidal activity of IFN-γ treated macrophages against Trypanosoma cruzi involves and L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by IL-10 and transforming growth factor. Eur. J. Immunol. 22 (1992) 2501-2506
17. Gomes J.A.S., Bahia Oliveira L.M.G., Rocha M.O.C., Martins Filho O.A., Gazzinelli G., and Correa Oliveira R. Evidence that development of severe cardiomyopathy in human Chagaś disease is due to a Th1-specific immune response. Infect. Immun. (2003) 1185-1193
18. Goñi O., Alcaide P., and Fresno M. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1+)CD11b+ immature myeloid supressor cells. Int. Immunol. 14 (2002) 1125-1134
19. Harris S.G., Padilla J., Koumas L., Ray D., and Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23 (2002) 144-150
20. Higuchi M.L., Benventuri L.A., Reis M.M., and Metzger M. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovas. Res. 60 (2003) 96-107
21. Hölscher C., Köhler G., Müller U., Mossmann H., Schaub G.A., and Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66 (1998) 1208-1215
22. Katamura K., Shintaku N., Yoriko Y., Fukui T., Ohshima Y., Mayumi M., and Furusho K. Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-γ and IL-2, but not IL-4 and IL-5. J. Immunol. 155 (1995) 4604-4612
23. La pointe M.C., Mendez M., Leung A., Tao Z., and Yang X.P. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H1416-H1424
24. Leon J.S., and Engman D.M. Autoimmunity in Chagas' heart disease. Int. J. Parasitol. 31 (2001) 555-561
25. Marinho C.R.F., Lima M.R.D., Grisotto M.G., and Alvarez J.M. Influence of acute phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagaś disease. Infect. Immun. (1999) 308-318
26. Martins G.A., Vieira L.Q., Cunha F.Q., and Silva J.S. Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect. Immun. 67 (1999) 3864-3871
27. Melo R.C.N., and Machado C.R.S. Trypanosoma cruzi: peripheral blood monocytes and heart macrophages in the resistance to acute experimental infection in rats. Exp. Parasitol. 97 (2001) 15-23
28. Michelin M.A., Silva J.S., and Cunha F.Q. Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection. Exp. Parasitol. 111 (2005) 71-79
29. Ouaissi A., Da Silva A.C., Guevara A.G., Borges M., and Guilvard E. Trypanosoma cruzi-induced host immune system dysfunction: a rationale for parasite immunosuppressive factor(s) encoding gene targeting. J. Biomed. Biotechnol. 1 (2001) 11-17
30. Petray P., Corral R., Meckert P.C., and Laguens R. Role of macrophage inflammatory protein-1α (MIP-1α) in macrophage homing in the spleen and heart pathology during experimental infection with Trypanosoma cruzi. Acta Tropica. 83 (2002) 205-211
31. Phipps R.P., Stein H.S., and Roper R.L. A new view of prostaglandin E regulation of the immune response. Immunol. Today 12 (1991) 349-352
32. Pinge Filho P., Tadokoro C.E., and Abrahamsohn I. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell. Immunol. 193 (1999) 90-98
33. Prata A. Classificação da infecção chagásica no homem. Rev. Soc. Bras. Med. Trop. 23 (1990) 109-113
34. Punukollu G., Gowda R.M., and Khan I.A. Early twentieth century descriptions of the Chagas Herat disease. Int. J. Cardiol. 95 (2004) 347-349
35. Reis M.M., Higuchi M.L., Benvenuti L.A., Aiello V.D., Gutierrez P.S., Bellotti G., and Pileggi F. An in situ quantitative immunohistochemical study of cytokines and IL-2R in Chronic Human Chagasic Myocarditis: correlation with the presence of myocardial T. cruzi antigens. Clin. Immunol. Immunopathol. 83 (1997) 165-172
36. Roper R.L., et al. Prostaglandin E2 promotes IL-4-induced IgE and IgG1 synthesis. J. Immunol. 145 (1990) 2644-2651
37. Roper R.L., and Phipps R.P. Prostaglandin E2 regulation of the immune response. Adv. Prostaglandin Thromboxane Leukot. Res. 22 (1994) 101-111
38. Sheng G.G., et al. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology 113 (1997) 1883-1891
39. Silva J.S., Vespa G.N.R., Cardoso M.A.G., Aliberti J.C.S., and Cunha F.Q. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect. Immun. 63 (1995) 4862-4867
40. Soares M.B.P., Silva Mota K.N., Lima R.S., Bellintani M.C., Pontes de Carvalho L., and Ribeiro dos Santos R.R. Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism. Am. J. Path. 159 (2001) 703-709
41. Sterin Borda L., Gorelik G., Goren N., Cappa S.G., Celentano A.M., and Borda E. Lymphocyte muscarinic cholinergic activity and PGE2 involvement in experimental Trypanosoma cruzi infection. Clin. Immunol. Immunopathol. 81 (1996) 122-128
42. Takle G.B., and Snary D. South American trypanosomiasis (Chagaś disease). In: Warren K.S. (Ed). Immunology of Parasite Infections (1993), Blackwell Scientific Publications 213
43. Tarleton R.L. Tumor necrosis factor (cachectin) production during experimental Chagaś disease. Clin. Exp. Immunol. 73 (1988) 186-190
44. Une C., Andersson J., and Örn A. Role of IFN-α/β and IL-12 in the activation of natural killer cells and IFN-γ production during experimental infection with Trypanosoma cruzi. Clin. Exp. Immunol. 134 (2003) 195-201
45. Walker C., Kristensen F., Betten F., and De Weck A.L. Lymphokine regulation of activated (G1) Prostaglandin E2-induced inhibition of interleukin-2 production. J. Immunol. 130 (1983) 1770-1773